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2750ABSTRACT
Background and aims. Postoperative hypoalbuminemia, especially following liver
transplantation, can lead to adverse multisystem effects and even death. We investigated
the relationship between postoperative albumin levels and organ failure (assessed using
Sequential Organ Failure Assessment [SOFA] scores).
Methods. Sixty liver transplant recipients admitted to the intensive care unit (ICU)
from 2012 to 2015 were retrospectively divided into 2 groups: lower albumin (LA) (n¼28)
and higher albumin (HA) (n¼32), using whether serum albumin level fell below 3.0 g/dL
during the first postoperative week as the stratifying factor. The SOFA scores (primary
endpoint) and associated complications (ascites amount, rejection, re-intubation,
abdominal re-operation, thrombosis), additional treatment (dialysis, pleural effusion
drainage), and duration of ICU stay (secondary endpoints) of the 2 groups were
compared.
Results. Average serum albumin levels were significantly different between HA and LA
groups (3.6 [3.4e3.8] vs 3.1 [2.9e3.3], respectively, P< .05), although the amounts of albumin
infused in the 2 groups during the first postoperative week were not different (HA vs LA: 42
[30e71] vs 40 [30e58], respectively, P¼ .37). Mean daily SOFA scores were not significantly
different between the HA and LA groups (8.3 [6.6e9.0] vs 7.2 [6.3e8.6], P¼ .73), although the
HA group had lower mean cardiovascular SOFA sub-scores than the LA group (0.1 [0e0.4] vs
0.4 [0e1.3], P¼ .032). There were no significant differences between the groups with regard to
complication rates and duration of ICU and hospital stays.
Conclusions. Serum albumin level might not influence cumulative organ function, but it
decreases the amount of hemodynamic support required in liver transplant recipients.*Address correspondence to Takashi Matsusaki, MD, PhD,
Department of Anesthesiology and Resuscitology, Okayama
University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-
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E-mail: matusakik@ybb.ne.jpALBUMIN is a product of hepatic protein synthesis andplays an essential role in the generation of colloid-
osmotic pressure. Hypoalbuminemia, which is frequently
observed in hospitalized patients, can be associated with
several different diseases, including cirrhosis, malnutrition,
nephrotic syndrome, and sepsis. Regardless of its cause,
hypoalbuminemia has strong predictive value in terms of
mortality and morbidity. The traditional use of albumin for
volume expansion, the potential therapeutic role of albumin
in liver disease, and the role of albumin therapy in nutrition
have been the focus of studies all over the world [1,2].9
rg/10.1016/j.transproceed.2019.01.199Postoperative hypoalbuminemia is common in liver
transplant recipients and is used as an indicator of post-
operative outcome. The negative effects of postoperative
hypoalbuminemia have been long known and several papersª 2019 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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SERUM ALBUMIN LEVELS AND ORGAN DYSFUNCTION 2751have addressed this subject [2,3]. Retrospective analyses
showed that postoperative hypoalbuminemia is associated
with postoperative mortality and acute kidney injury [3,4].
However, whether or not this hypoalbuminemia should be
corrected is controversial [5e7], and correct timing and
volume for albumin supplementation during the perioper-
ative period is not yet known. Additionally, little is known
about prolonged elevation in serum albumin concentrations’
effect on organ function.
We aimed to evaluate the impact of postoperative human
albumin levels on organ function during the first post-
operative week in recipients of orthotopic and living donor
liver transplantations.MATERIALS AND METHODS
This retrospective study involved 60 patients who underwent liver
transplantation for hepatic failure between May 2012 and
December 2015 at Okayama University Hospital. Patients who had
multiple organ transplantations and those younger than 16 years of
age were excluded. The study was approved by the institutional
review board of our hospital and informed consent was obtained
from patients or their guardians. The study was performed in
accordance with the ethical standards of the Declaration of
Helsinki.
We included only consecutive patients. We noted the patients’
preoperative data (age, sex, height, weight, body mass index),
underlying disease (etiology: liver cirrhosis from viral infection or
non-viral, fulminant hepatitis), Model for End-stage Liver Disease
scores, Child-Pugh scores, serum albumin level, and type of liver
transplantation from their charts as the clinical variables. Intra-
operative data (surgical time, cold and warm ischemia time, anhe-
patic time, estimated blood loss, transfusions, and graft weight/
recipient weight ratio), and postoperative data (serum albumin
level, amount of albumin infused, and transfusion volume) during
the first postoperative week were also noted using the patients’
hospital medical records. Intraoperative blood loss was estimated
using the gauze count and suction volume from the surgical field.
The primary endpoint evaluated was the relationship between
postoperative Sequential Organ Failure Assessment (SOFA) scores
and serum albumin levels. In this score, lower scores indicate better
organ function during the first postoperative week. Secondary
endpoints were perioperative complications (rejection, re-
intubation, abdominal re-operation, thrombosis, ascites, re-
transplantation), additional treatment required (dialysis, pleural
effusion drainage), and duration of intensive care unit (ICU) and
hospital stay. Although we do not have a definite protocol for serum
albumin supplementation at our institute, we try to maintain albu-
min levels above 3.0 g/dL if possible. Hence, we divided the patients
into 2 groups. Patients whose serum albumin levels were above 3.0
g/dL during the first week after surgery were included in the higher
albumin (HA) group, while the lower albumin (LA) group included
patients whose serum albumin levels fell below 3.0 g/dL at least
once. We routinely gave all the patients a 5% albumin and crys-
talloid infusion for at least 5 or 7 days post-operation according to
the amount of ascitic fluid issuing from the drainage tube, to
maintain serum albumin levels at a higher level (> 3.0 g/dL) and
maintain intravascular volume. Our transfusion protocol also
included administration of fresh frozen plasma to maintain pro-
thrombin activity at> 40%. If possible, we tried to provide all pa-
tients with nutritional support via a nasal tube as soon as possibleafter surgery [8]. The assessed parameters were compared between
the 2 groups.
Data are presented as percentages (n) or as median (25% quar-
tile, 75% quartile) for continuous variables. Categorical data are
presented as proportions. Differences between groups were
assessed using the Mann-Whitney U test for continuous variables,
and Fisher exact test or c2 test for categorical variables. We
considered a value of P< .05 to indicate a significant difference.
JMP version 11 software (SAS Institute, Cary, NC, United States)
was used for statistical analyses.RESULTS
There were no significant differences between the groups with
regard to preoperative, intraoperative, or postoperative vari-
ables (Table 1). As was to be expected, average serum albumin
levels during the postoperative periodwere significantly higher
in theHA group compared to the LA group, except at the time
of ICU admission. An average of 30 to 50 g of albumin was
infused daily in both groups during the first week after surgery,
except at the time of ICU admission. The amount of albumin
infused during the first postoperative week in the HA group
was not statistically significantly greater than in the LA group
(304 [212e509] vs. 283 [210e406] g, respectively,P¼.44). There
were no significant differences in mean daily SOFA scores
between the HA and LA groups (8.3 [6.6e9.0] vs 7.2 [6.3e8.6],
P¼ .73). Daily SOFA scores gradually decreased during the
postoperative period in both groups (Fig 1). There was no
significant relationship between serum albumin levels and
SOFA scores, although the HA group had a lower mean car-
diovascular SOFA sub-score than the LA group (0.1 [0e0.4] vs
0.4 [0e1.3], P¼ .032). There were no significant differences
between the 2 groups in terms of neurologic (0.8 [0.5e1.5] vs
0.6 [0.4e1.0], P¼ .19), hepatic (2.3 [2e2.7] vs 1.9 [1.5e2.5],
P¼ .10), respiratory (1.5 [1.2e1.8] vs 2.0 [0.8e2.3], P¼ .20),
coagulation (2.3 [1.9e2.5] vs 2.3 [1.9e2.5], P¼ .76), or renal
SOFAscores (0.0 [0.0e0.8] vs. 0.0 [0.0e0.4],P¼.17) (Fig 2), nor
were there any significant differences between the groups in
the rate of occurrence of complications (rejection, re-
intubation, abdominal re-operation, thrombosis, re-
transplantation), need for additional treatment (dialysis,
pleural effusion drainage), or duration of ICU and hospital
stay (Table 1).DISCUSSION
In this study, we found that maintenance of serum albumin
levels at > 3.0 g/dL during the first postoperative week in
liver transplant recipients does not protect against organ
injury as assessed using daily SOFA scores. A higher albu-
min level did, however, decrease the need for postoperative
catecholamine support.
Definitive guidelines regarding the appropriate level that
serum albumin should be maintained at post-operation have
not been established, although it is believed that maintain-
ing higher albumin levels reduces the amount of abdominal
or thoracic fluid collection in transplant recipients. Tradi-
tionally, in our hospital, the amount of serum albumin and
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drainage volume, the aim being to maintain intravascular
volume post-operation. Per Ito et al [9], low postoperative
albumin levels, which reflect a decreased functional reserve
of the liver, are likely to cause ascites and prolong hospital
stays following liver resections for hepatocellular carci-
nomas. However, there is controversy regarding post-
operative albumin infusion. Mukhtar et al [5] found no
difference in hemodynamic variables or postoperative
complications following infusion of human albumin or pla-
cebo in living donor liver transplant recipients. Yet, Ertmer
et al [6] reported that continuous infusion of albumin might
preserve cumulative organ function (as measured by SOFA
scores), especially cardiovascular function, in patients un-
dergoing orthotopic liver transplantation. Their study differs
from ours in that albumin was not administered to their
study’s control group, although the higher albumin level did
not affect postoperative complications and mortality, as
with our results. While the exact amount of serum albumin
infused in their study was not mentioned, their maintenanceTable 1. Baseline Characteristic
LA Group (n¼ 28)
Preoperative Data
Age (y) 54 (51e61)
Male sex 14 (50.0)
BMI (kg/m2) 23.8 (20.6e26.1)
Child-Pugh score 11 (10e12)
MELD score 17 (13e21)
Viral liver cirrhosis 11 (39.3)
Non-viral liver cirrhosis 17 (60.7)
Fulminant hepatitis 0 (0.0)
LDLT 23 (82.1)
Intraoperative data
Duration of anesthesia (min) 664 (595e728)
Duration of surgery (min) 546 (494e593)
Cold ischemia time 76 (37e137)
Warm ischemia time 43 (35e47)
Anhepatic time 152 (114e193)
GW/RBW (%) 1.09 (0.92e1.59)
Blood loss (mL) 4517 (3184e8218)
Urine output (mL) 1024 (660e1488)
Infusion volumes
Crystalloids (mL) 2674 (2126e3540)
HES (mL) 800 (0e1500)
5% Albumin (mL) 2625 (1738e3313)
RBCs (mL) 1960 (1400e2800)
FFP (mL) 2520 (1680e3360)
Platelets (mL) 400 (200e400)
Ascites (mL) 500 (0e2600)
Postoperative data
RBCs (mL) 280 (0e560)
FFP (mL) 1200 (480e1740)
Platelets (mL) 200 (150e600)
Ascites (mL) 9830 (7465e14506)
Data are presented as n (%) or as median (25% quartile, 75% quartile). Postopera
Abbreviations: BMI, body mass index; FFP, fresh frozen plasma; GW/RBW, graft w
lower albumin; LDLT, living donor liver transplantation; MELD, Model for End-stageserum albumin level of > 2.8 g/dL reportedly reduced acute
kidney injury until postoperative day 3. Although hypo-
albuminemia is known to reflect delayed graft function, al-
bumin levels were not associated with graft function or
other complications in our study.
The mechanisms and clinical implications of the post-
operative decrease in serum albumin levels following hepatic
transplantation remain unclear. Surgical stress and delayed
graft function are likely associated with the decrease in serum
albumin levels in liver transplant recipients. Labgaa et al [10]
reported in a prospective cohort study from Europe that a
postoperative decrease in serum albumin (especially by 1.0
g/dL on postoperative day 1) is a predictor of early complica-
tions followingmajor abdominal surgery.Hübner et al [11] also
showed that a decrease in postoperative albumin levels is a
marker of surgical stress and a predictor of clinical outcome.
Replenishing this deficit by infusing albumin might prevent
serious postoperative complications.
Our target albumin level of> 3.0 g/dLwas high compared to
other reports and the study period (1 week after surgery) wass of the Study Participants
HA Group (n¼ 32) P
55 (46e62) .50
16 (50.0) 1
22.8 (20.6e25.4) .40
11 (10e12) .63
19 (15e22) .18
12 (37.5) .89
17 (53.1) .29
3 (9.4) .08
29 (90.6) .35
645 (561e737) .88
526 (459e632) .83
48 (37e95) .22
44 (33e54) .49
168 (137e201) .50
1.04 (0.75e1.29) .15
4033 (2680e7688) .44
905 (625e1138) .34
2335 (1517e5001) .98
750 (0e1500) .88
2250 (1500e3313) .68
1960 (1120e3080) .91
2640 (1680e3180) .86
200 (200e450) .75
125 (0e1538) .41
280 (0e350) .40
1560 (660e2220) .13
400 (200e600) .24
10719 (5948e19374) .34
tive data is total volume over 7 days.
eight/recipient weight ratio; HES, hydroxyethyl starch; HA, higher albumin; LA,
Liver Disease; RBCs, red blood cells.
Fig 1. Mean daily SOFA scores in the 2 groups in the first week
after transplantation. There were no significant differences in
mean daily SOFA scores between the HA and LA groups (8.3
[6.6e9.0] vs 7.2 [6.3e8.6], P¼ .73). Abbreviations: HA, higher
albumin level; LA, lower albumin level; SOFA, Sequential Organ
Failure Assessment.
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bumin infusion protocol and maintain higher albumin levels
for 3 days rather than 7 days after transplantation.
We used SOFA scores to assess organ function in our
study. Other scores besides the SOFA score can also beFig 2. Cardiovascular SOFA sub-scores in the 2 groups. The HA gro
group (0.1 [0e0.4] vs 0.4 [0e1.3], P¼ .03). There were no significan
[0.5e1.5] vs 0.6 [0.4e1.0], P¼ .19), hepatic (2.3 [2.0e2.7] vs 1.9 [1.5e
coagulation (2.3 [1.9e2.5] vs 2.3 [1.9e2.5], P¼ .76), and renal SOFA
HA, higher albumin level; LA, lower albumin level; SOFA, Sequentialused for assessment of organ injury, such as the Simplified
Acute Physiology Score or Acute Physiologic Assessment
and Chronic Health Evaluation score [12,13]. Daily assess-
ment of SOFA scores is now common in the ICU setting,
especially in transplant recipients, since their pathophysi-
ology might change significantly from infection or acute
cellular rejection. Hence, we chose daily SOFA scores to
assess organ injury, like Ertmer’s study [6].
Our study indicated improvement in cardiovascular per-
formance (as judged by reduced vasopressor requirements
and improved cardiovascular SOFA sub-scores) in the HA
group compared to the LA group. We believe that this may
have resulted from several mechanisms, including mobili-
zation of extravascular fluid into the intravascular
compartment. Since we did not measure any oncotic pres-
sure parameters, we cannot definitively state the mechanism
of the improved cardiovascular performance with higher
albumin levels. Albumin offers several benefits: it scavenges
radical oxygen species, has anticoagulant properties, limits
tubular cell apoptosis, is intimately related to fluid move-
ment across the endothelial barrier, and is central to
maintaining adequate microvascular blood flow [14], all of
which are crucial in the perioperative period.
Our study has certain limitations. This study was a small
retrospective analysis conducted at a single center. We did
not follow any definite criteria regarding albumin infusion.
Our control group (the LA group) received the same
amount of albumin infusion during the first postoperative
week as the HA group. Therefore, it might be difficult to
strictly confirm the significance of albumin infusion basedup had lower mean cardiovascular SOFA sub-scores than the LA
t differences between the 2 groups in terms of neurologic (0.8
2.5], P¼ .10), respiratory (1.5 [1.2e1.8] vs 2.0 [0.8e2.3], P¼ .20),
scores (0.0 [0.0e0.8] vs 0.0 [0.0e0.4], P¼ .17). Abbreviations:
Organ Failure Assessment.
2754 HIROI, MATSUSAKI, KAKU ET ALon our results. Furthermore, we could not examine the
mechanism of the lower cardiovascular SOFA scores in the
HA group because we did not measure osmotic pressure.
CONCLUSION
Our results suggest that while serum albumin levels might
not influence cumulative organ function (as measured by
the SOFA score), maintaining serum albumin levels above
3.0 g/dL may reduce the amount of hemodynamic support
required in liver transplant recipients.
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